Axsome Therapeutics Statistics
Total Valuation
AXSM has a market cap or net worth of $6.72 billion. The enterprise value is $6.60 billion.
Important Dates
The last earnings date was Tuesday, February 18, 2025, before market open.
| Earnings Date | Feb 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AXSM has 48.77 million shares outstanding. The number of shares has increased by 5.48% in one year.
| Current Share Class | 48.77M |
| Shares Outstanding | 48.77M |
| Shares Change (YoY) | +5.48% |
| Shares Change (QoQ) | +0.83% |
| Owned by Insiders (%) | 1.42% |
| Owned by Institutions (%) | 69.59% |
| Float | 36.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 17.11 |
| Forward PS | 12.01 |
| PB Ratio | 117.58 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 17.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 3.38.
| Current Ratio | 2.11 |
| Quick Ratio | 1.99 |
| Debt / Equity | 3.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -38.43 |
Financial Efficiency
Return on equity (ROE) is -231.63% and return on invested capital (ROIC) is -50.30%.
| Return on Equity (ROE) | -231.63% |
| Return on Assets (ROA) | -27.28% |
| Return on Invested Capital (ROIC) | -50.30% |
| Return on Capital Employed (ROCE) | -74.60% |
| Revenue Per Employee | $707,694 |
| Profits Per Employee | -$527,002 |
| Employee Count | 545 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 2.16 |
Taxes
In the past 12 months, AXSM has paid $85,000 in taxes.
| Income Tax | 85,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.77% in the last 52 weeks. The beta is 1.05, so AXSM's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | +69.77% |
| 50-Day Moving Average | 101.36 |
| 200-Day Moving Average | 89.77 |
| Relative Strength Index (RSI) | 74.55 |
| Average Volume (20 Days) | 1,156,502 |
Short Selling Information
The latest short interest is 5.61 million, so 11.50% of the outstanding shares have been sold short.
| Short Interest | 5.61M |
| Short Previous Month | 5.75M |
| Short % of Shares Out | 11.50% |
| Short % of Float | 15.29% |
| Short Ratio (days to cover) | 5.64 |
Income Statement
In the last 12 months, AXSM had revenue of $385.69 million and -$287.22 million in losses. Loss per share was -$5.99.
| Revenue | 385.69M |
| Gross Profit | 352.39M |
| Operating Income | -252.44M |
| Pretax Income | -309.56M |
| Net Income | -287.22M |
| EBITDA | -244.48M |
| EBIT | -252.44M |
| Loss Per Share | -$5.99 |
Full Income StatementBalance Sheet
The company has $315.35 million in cash and $192.96 million in debt, giving a net cash position of $122.40 million or $2.51 per share.
| Cash & Cash Equivalents | 315.35M |
| Total Debt | 192.96M |
| Net Cash | 122.40M |
| Net Cash Per Share | $2.51 |
| Equity (Book Value) | 57.02M |
| Book Value Per Share | 1.17 |
| Working Capital | 254.96M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$128.41 million and capital expenditures -$270,000, giving a free cash flow of -$128.68 million.
| Operating Cash Flow | -128.41M |
| Capital Expenditures | -270,000 |
| Free Cash Flow | -128.68M |
| FCF Per Share | -$2.64 |
Full Cash Flow StatementMargins
Gross margin is 91.37%, with operating and profit margins of -65.45% and -74.47%.
| Gross Margin | 91.37% |
| Operating Margin | -65.45% |
| Pretax Margin | -74.45% |
| Profit Margin | -74.47% |
| EBITDA Margin | -63.39% |
| EBIT Margin | -65.45% |
| FCF Margin | n/a |
Dividends & Yields
AXSM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.48% |
| Shareholder Yield | -5.48% |
| Earnings Yield | -4.28% |
| FCF Yield | -1.92% |
Dividend DetailsAnalyst Forecast
The average price target for AXSM is $158.93, which is 15.38% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $158.93 |
| Price Target Difference | 15.38% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 44.63% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AXSM has an Altman Z-Score of 1.71 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.71 |
| Piotroski F-Score | 3 |